Related Experiment Video

Updated: Jun 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients

Shao Hua Shi1, Hai Shen Kong, Chang Ku Jia

  • 1Department of Hepatobiliary Surgery and Center of Liver Transplantation, The First Affiliated Hospital, Medical College, Zhejiang University, Hangzhou, China. sms3391@hotmail.com

Clinical Transplantation
|January 6, 2010
PubMed

Insights

Pneumonia from multidrug-resistant (MDR) Gram-negative bacilli is common after liver transplants (LT) and increases mortality. Risk factors include encephalopathy, prolonged ventilation, tracheostomy, and reoperations, highlighting the need for targeted empiric therapy.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Critical Care

Background:

  • Pneumonia caused by multidrug-resistant (MDR) Gram-negative bacilli poses a significant threat in immunocompromised patients, particularly liver transplant (LT) recipients.
  • Understanding local resistance patterns is crucial for effective empiric antibiotic therapy in post-LT pneumonia.

Purpose of the Study:

  • To investigate the spectrum of Gram-negative bacilli, MDR rates, associated risk factors, and mortality in liver transplant recipients.

Main Methods:

  • A retrospective study analyzing 475 liver transplantation recipients.
  • Bacterial pneumonia incidence, pathogen identification, and MDR rates were determined.
  • Statistical analysis was performed to identify risk factors and mortality predictors.

Main Results:

  • Bacterial pneumonia occurred in 21.3% of LT recipients within six months post-transplant.
  • Gram-negative bacilli constituted 69.6% of pneumonia pathogens, with an MDR rate of 58.9%.
  • Key risk factors identified included pre-LT encephalopathy, prolonged endotracheal intubation, tracheostomy, and post-LT reoperations. MDR pneumonia had a significantly higher mortality rate (45.6% vs. 11.4%).

Conclusions:

  • Pneumonia caused by MDR Gram-negative bacilli is a frequent and severe complication after liver transplantation.
  • Severity of the underlying disease, prolonged mechanical ventilation, and abdominal surgery are associated with increased risk.
  • These findings underscore the importance of vigilant monitoring and tailored treatment strategies for MDR infections in LT patients.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...